ABIGAIL MASTERS: Open Payments
NPI 1881221893 · KENDALLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 27 payments from 15 companies in 2025. Trend: 2023 $333 · 2024 $470 · 2025 $513
Food & beverage: $468Education: $45
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $101 |
| AstraZeneca Pharmaceuticals LP | 4 | $78 |
| ABBVIE INC. | 4 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Astellas Pharma US Inc | 1 | $25 |
| Corium, LLC | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| SANOFI PASTEUR INC. | 1 | $18 |
Products named: Kerendia, VRAYLAR, BREZTRI, JARDIANCE, FARXIGA, XIFAXAN, Veozah, Azstarys.
Industry payments across IN — which companies pay providers there.
